Pro Medicus Limited (PME)

Views and News

A Global Leader in IT for Radiology

Pro Medicus is a leading medical IT and e-health provider. Founded in 1983, it now provides a full range of integrated software products and services to individual, corporate and public health providers.

More than 26,000 Australian doctors are connected to the company’s e-health service, promedicus.net.

Early in 2009 PME acquired Visage Imaging, a leader in 3D visualization technology. As a result, PME now has a suite of leading-edge 3-dimensional Picture Archiving and Communication System (PACS) and advanced visualisation products which, combined with its Practice Management (RIS) and e-health solutions, constitutes one of the most comprehensive “end-to-end” solutions for the radiology profession.

Pro Medicus employs more than 70 people in Melbourne, Berlin and San Diego. In May 2013 it signed a pivotal deal with vRad, one of the largest radiology groups in North America, which has begun using Pro Medicus’ Visage technology as a key part of its technology platform.

On 21 November 2013, PME announced that its first Visage 7 implementation had gone live as a key component of vRad's 'RG2' next-generation radiology operational management solution. It delivers industry leading performance, enabling instant screening and comparison and storage of the most high quality pictures, increasing productivity and faster and better decision making. This triggers a five-year contract period and paves the way for further installations across vRad's US network.


Recent News Highlights

As at 24/01/2012 : see details at www.promedicus.com.au

22/12/2011         


Half-yearly Performance & Estimates - PME

Year-end June FY11A 1H12A FY12A 1H13A FY13A FY14E FY15E
Sales, $m 14.0 7.4 12.2 5.8 11.1 0.00 0.00
EBITDA, $m 3.6 3.4 3.9 -3.6 -2.2 0.00 0.00
EBIT, $m 0.60 1.6 0.95 -5.1 -5.2 0.00 0.00
Report NPAT, $m 0.50 1.1 1.8 4.8 -3.5
Adj. NPAT, $m -3.5 0.00 0.00
Reported EPS, ¢ 1.00 1.00 2.00 5.00 -3.00
Adjusted EPS, ¢ -3.00 0.00 0.00
EPS %FY/Growth 50% 100% -167% -250% -100% ****%
Dividend, ¢ 0 0.50 1.5 1.00 11.0 0.00 0.00
Franking, % - 100% 100% 100% 100% 100% 100%
EBITDA Margin 26% 0 0 -62% -20% ******% ******%
NPAT Margin 4% 0 0 -67% -31% ******% ******%
ROE, % 3% 0 11% -18 -17%
EBIT/Interest -5.9 0.0 -14.4 223.0 23.28
Net Debt / Equity -0.21 0 -0.32 -0.87 -0.86
CashFlow/Sh, ¢ 6.3 2.5 5.9 0.7 3.9 0.00 0.00
Y/E Shares, m 100.3 100.3 100.3 100.3 100.3
Notes
Data sourced from IRESS Market Technology Limited. EPS Growth compared with the pcp is shown in most columns, except 1H11A and 1H12A which show the first half % of full year EPS. In a handful of cases, unadjusted share splits may give strange changes in ratios.


Company Overview


                Profile

Pro Medicus

Rating:    

Category:    ;     

Action:        

Website:    www.promedicus.com.au

ASX code: PME
Closing Price, 09/05/14: $ 0.840
Market Capitalisation: $ 84 million
52 Week High: $ 0.90
52 Week Low: $ 0.40
Sector: Health Care Equipment & Services
Index: S&P/ASX Index

Summary of Fundamentals

Year-end June FY12A FY13A FY14E FY15E
NPAT, $m 1.8 -3.5 0.0 0.0
Reported EPS, ¢ 2.00 -3.00
Adjusted EPS, ¢ 0.00 0.00 0.00
EPS Growth, % 100% -100% **********%
P/E Ratio, x 42.00
Dividend, ¢ 1.5 11.0 0.00 0.00
Franking, % 100% 100% 100% 100%
Div. Yield, % 1.79 13.10 0.00 0.00

Notes

Our Adjusted EPS is used for the last year and forward estimates and as basis for EPS Growth and P/E Ratio. We currently use Reported data for all historic NPAT, for the prior year EPS and as base for last year EPS growth.
Data & Chart sourced from IRESS Market Technology Ltd.

One Year Chart

As at 23 June 2014 PME.png

Other Highlights

Sector: Health Care Equipment & Services
Return on Equity, FY13 : -17%
Net Debt to Equity, FY13 : -86 %
EBIT / Interest Cover, FY13 : 23.28 x
Gicscode: 35100000
First Listed: 10-Oct-00

Business Activities

Pro Medicus Limited (PME) is a provider of IT solutions and services including training and installation, hardware configuration and ongoing technical and end user support to the private healthcare industry.



Glossary:

      "A Core Stock" - reliable long-term yield & growth
     "We like it" - a seasoned performer, growth & yield
     "A tough scout" - creating a potential breakthrough
     "A steady performer" - giving reliable yield or growth
  Best Stocks   Portfolio of selected attractive investments
  Potential   Stocks that may have good improvement prospects
  Speculative   More risky usually smaller stocks with spec. upside
  Midcaps    In RR Midcap Index, $ 70m to 1,500m market cap.
  Large Stocks   Larger Stocks upwards of $ 1,500m market cap





back to top